# Quantum Biopharma Ltd.: financial statements, quarterly

QNTM · Nasdaq · CIK 1771885 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/qntm.md) · [Financials](/companies/qntm/financials.md) · [Filings](/companies/qntm/filings.md) · [Insiders](/companies/qntm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/qntm/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [15.9](/filings/0001062993-22-009034.md) | [6.0](/filings/0001062993-23-008232.md) | [17.5](/filings/0001062993-23-008232.md) | [35.3](/filings/0001062993-23-008232.md) | [17.0](/filings/0001185185-26-001069.md) | [2.8](/filings/0001185185-26-001069.md) | [6.0](/filings/0001185185-26-001069.md) | [1.9](/filings/0001185185-26-001069.md) |
| Current assets | $m | [17.0](/filings/0001062993-21-002769.md) | [8.6](/filings/0001062993-21-002769.md) | [26.9](/filings/0001062993-22-009034.md) | [45.9](/filings/0001062993-23-008232.md) | [17.9](/filings/0001654954-24-004067.md) | [11.1](/filings/0001654954-25-003693.md) | [12.1](/filings/0001185185-26-001069.md) | [6.5](/filings/0001185185-26-001069.md) |
| Total assets | $m | [39.7](/filings/0001062993-21-002769.md) | [43.2](/filings/0001062993-21-002769.md) | [42.0](/filings/0001062993-22-009034.md) | [63.0](/filings/0001062993-23-008232.md) | [38.4](/filings/0001654954-24-004067.md) | [17.5](/filings/0001654954-25-003693.md) | [17.1](/filings/0001185185-26-001069.md) | [11.2](/filings/0001185185-26-001069.md) |
| Current liabilities | $m | [1.3](/filings/0001062993-21-002769.md) | [6.8](/filings/0001062993-21-002769.md) | [5.6](/filings/0001062993-22-009034.md) | [8.7](/filings/0001062993-23-008232.md) | [7.8](/filings/0001654954-24-004067.md) | [4.6](/filings/0001654954-25-003693.md) | [6.7](/filings/0001185185-26-001069.md) | [6.1](/filings/0001185185-26-001069.md) |
| Total liabilities | $m | [1.3](/filings/0001062993-21-002769.md) | [6.9](/filings/0001062993-21-002769.md) | [5.7](/filings/0001062993-22-009034.md) | [8.8](/filings/0001062993-23-008232.md) | [7.9](/filings/0001654954-24-004067.md) | [4.6](/filings/0001654954-25-003693.md) | [6.7](/filings/0001185185-26-001069.md) | [6.1](/filings/0001185185-26-001069.md) |
| Shareholders' equity | $m | [38.4](/filings/0001062993-22-009034.md) | [36.3](/filings/0001062993-23-008232.md) | [36.3](/filings/0001654954-24-004067.md) | [54.1](/filings/0001654954-25-003693.md) | [30.5](/filings/0001654954-24-004067.md) | [13.2](/filings/0001654954-25-003693.md) | [11.5](/filings/0001185185-26-001069.md) | [6.9](/filings/0001185185-26-001069.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 12 at 2024-12-31, from the cover of the [20-F/A filed 2025-03-31](/filings/0001654954-25-003693.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.